Developing Non-Traditional Antibiotics (AAC ed.)
Listen now
Developing of non-traditional antibiotics promises novel strategies to combat multidrug-resistant organism but would they work? Are the feasible to develop? 

 Topics discussed: 
 • The notion of non-traditional antibiotics as potential therapeutics against MDR organisms 
 • Increasing our understanding on the clinical efficacy of non-traditional antibiotics 
 • Regulatory pathways for approval of such compounds
 Guest: Dr. John Rex, Chief Medical Officer, F2G Ltd. | Expert-in-Residence, Wellcome Trust.
 Visit to browse issues and/or submit a manuscript.
More Episodes
The Center of Diseases Control and Prevention (CDC) has categorized emergent resistance in Neisseria gonorrhoeae as an “urgent” public health problem. We discuss the emerging problem of gonorrhea and implications for public health with experts in the field Topics discussed: The clinical...
Published 03/24/23
We can probably all agree that any false positive test result is bad, but I think it’s safe to say that some false positives, like a false positive HIV test for example, is much more anxiety provoking than others. And when it comes to HIV, there have been a number of key advances in the field...
Published 02/24/23
Published 02/24/23